Left Ventricular Regional Wall Motion Abnormality is a StrongPredictor of Cardiotoxicity in Breast Cancer Patients UndergoingChemotherapy

摘要

BackgroundChemotherapeutic agents of anthracyclines class and humanized monoclonal antibodies are effective treatments for breast cancer, however, they present a potential risk of cardiotoxicity. Several predictors have been recognized as predictors in the development of cardiac toxicity, and the evaluation of left ventricular segmental wall motion abnormalities (LVSWMA) has not been studied.